3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Endocrine
2
CNS
2
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
13
Brain Neoplasms
12
Sarcoma
7
Meningioma
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Glioma
5
Esophageal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Solid Tumor, Adult
3
Rhabdomyosarcoma
3
Head and Neck Neoplasms
3
Chondrosarcoma
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Radiation Injuries
2
Pituitary Neoplasms
2
Pinealoma
2
Osteosarcoma
2
Oligodendroglioma
2
Nerve Sheath Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Liver Neoplasms
2
Hodgkin Disease
2
Gliosarcoma
2
Interventions
pasireotide
7
Cabergoline
7
Temozolomide
3
Propofol
3
Hydrocortisone
3
Dexmedetomidine
3
lanreotide
2
Sevoflurane
2
Saline Solution
2
Rosiglitazone
2
Proton Therapy
2
Octreotide
2
Dexamethasone
2
Desflurane
2
pegvisomant
1
parecoxib
1
lutetium Lu 177 dotatate
1
loxoprofen
1
farletuzumab
1
entinostat
1
corticorelin ovine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Yoga
1
Trimethoprim
1
Transcranial Magnetic Stimulation
1
Tranexamic Acid
1
Tramadol
1
Thyrotropin-Releasing Hormone
1
TBR-760
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Pituitary Neoplasms
×
Proton Therapy
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled
NCT06831461
2025-09-16
PRIDE
Tata Memorial Centre
Phase NA
Recruiting
156 enrolled